Subscribe to Newsletter
Manufacture Advanced Medicine, Bioprocessing - Single Use Systems, Small Molecules, Standards & Regulation

FDA or EMA Novel Drug Approvals 2024: Anagrams Edition

It’s Christmas: a time for fun and games! Below you will find a list of 14 anagrams of drug names approved for human use in 2024 by either the US FDA or the European Medicines Agency (Nemluvio, Balversa, Ordspono, Elevidys, Adstriladrin, Ojemda, Xolremdi, Tevimbra, Imdelltra, Niktimvo, Winrevair, Anktiva, Alhemo, Exblifep). Can you match them all without cheating? Let me know how you get on: [email protected]

  1. Vomit kin
  2. In volume 
  3. Mild later 
  4. Older mix 
  5. Doe jam 
  6. Via tank 
  7. Rin waiver 
  8. Brave Tim 
  9. Px belief 
  10. Spoon Rod 
  11. A holme 
  12. Lab raves 
  13. Trials and ID 
  14. Idle vyes 

Answers:

  1. Niktimvo 
  2. Nemluvio
  3. Imdelltra
  4. Xolremdi
  5. Ojemda
  6. Anktiva
  7. Winrevair
  8. Tevimbra
  9. Exblifep
  10. Ordspono
  11. Alhemo
  12. Balversa
  13. Adstriladrin 
  14. Elevidys 
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Rob Coker

Deputy Editor of The Medicine Maker

Following a Bachelor’s degree in English Literature and a Master’s in Creative Writing, I entered the world of publishing as a proofreader, working my way up to editor. The career so far has taken me to some amazing places, and I’m excited to see where I can go with Texere and The Medicine Maker.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register